Publication:
The Economics of Effective AIDS Treatment : Evaluating Policy Options for Thailand

Simple item page
dc.contributor.authorOver, Mead
dc.contributor.authorRevenga, Ana
dc.contributor.authorMasaki, Emiko
dc.contributor.authorPeerapatanapokin, Wiwat
dc.contributor.authorGold, Julian
dc.contributor.authorTangcharoensathien, Viroj
dc.contributor.authorThanprasertsuk, Sombat
dc.contributor.otherBrown, Tim
dc.contributor.otherDuncombe, Chris
dc.contributor.otherLertiendumrong, Jongkol
dc.contributor.otherPhongphit, Seri
dc.contributor.otherTantisak, Bussaba
dc.contributor.otherWilson, David
dc.date.accessioned2012-06-05T20:59:23Z
dc.date.available2012-06-05T20:59:23Z
dc.date.issued2006
dc.description.abstractThe purpose of this report is to advise the Thai government and Thai society at large about the full range of benefits, costs, and consequences that are likely to result from the decision to expand public provision of antiretroviral therapy (ART) through National Access to Antiretroviral Program for People Living with HIV/AIDS (NAPHA) and to assist with the design of implementation policies that will achieve maximum treatment benefits, while promoting prevention of HIV/AIDS and maintaining financial sustainability within Thailand. The study has several significant findings: NAPHA with first-line regimen only is the most cost-effective policy option of those studied; NAPHA with second-line therapy is still affordable and yields large benefits in terms of life-years saved; policy options to enhance adherence and to recruit patients earlier are a good public investment; public financing will help ensure equitable access; public financing can strengthen positive spillovers and can limit negative spillovers of ART; if the success of ART rollout makes people or the government complacent about prevention, future costs could rise substantially; and future government expenditures on ART, and the lives it will save are highly sensitive to negotiated agreements on the intellectual property rights for pharmaceuticals. In its current form, Thailand's NAPHA program is affordable. Under the model's assumptions, it is also cost-effective relative to the baseline scenario. Furthermore, although the two enhanced policies we suggest early recruitment through expanded voluntary counseling and testing (VCT) and improved adherence through Person living with HIV/AIDS (PHA) groups are less cost-effective, they are still a good bargain, particularly if both are enacted.en
dc.identifierhttp://documents.worldbank.org/curated/en/2006/01/7082805/economics-effective-aids-treatment-evaluating-policy-options-thailand
dc.identifier.doi10.1596/978-0-8213-6755-1
dc.identifier.isbn978-0-8213-6755-1
dc.identifier.urihttps://hdl.handle.net/10986/7196
dc.languageEnglish
dc.language.isoen_US
dc.publisherWashington, DC: World Bank
dc.relation.ispartofseriesHealth, Nutrition, and Population
dc.rightsCC BY 3.0 IGO
dc.rights.holderWorld Bank
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/igo
dc.subjectACQUIRED IMMUNODEFICIENCY SYNDROME
dc.subjectAIDS COMMITTEE
dc.subjectAIDS DEATHS
dc.subjectAIDS EPIDEMIC
dc.subjectAIDS PATIENTS
dc.subjectAIDS SPENDING
dc.subjectAIDS TREATMENT
dc.subjectBEHAVIORAL CHANGE
dc.subjectBEHAVIORAL SURVEILLANCE
dc.subjectBLOOD DONORS
dc.subjectCANCER
dc.subjectCASE OF AIDS
dc.subjectCELL COUNT
dc.subjectCLINICS
dc.subjectCOMMERCIAL SEX
dc.subjectCOMMERCIAL SEX WORKERS
dc.subjectCOMPLICATIONS
dc.subjectCOMPREHENSIVE CARE
dc.subjectCONDOM
dc.subjectCONDOM DISTRIBUTION
dc.subjectCONDOM USE
dc.subjectCONDOMS
dc.subjectCONSISTENT USE OF CONDOMS
dc.subjectCOST EFFECTIVENESS
dc.subjectDEVELOPING COUNTRIES
dc.subjectDIAGNOSTIC TESTS
dc.subjectDISCRIMINATION
dc.subjectDISEASE
dc.subjectDISEASES
dc.subjectDISSEMINATION
dc.subjectDISTRICT HOSPITAL
dc.subjectDOSE COMBINATION
dc.subjectDRUG REGIMENS
dc.subjectDRUG USER
dc.subjectDRUGS
dc.subjectEPIDEMIOLOGY
dc.subjectEXTRAMARITAL SEX
dc.subjectFEMALE SEX PARTNERS
dc.subjectFEMALE SEX WORKERS
dc.subjectGLOBAL AIDS PROGRAM
dc.subjectGOVERNMENT AGENCIES
dc.subjectHEALTH
dc.subjectHEALTH CARE
dc.subjectHEALTH INSURANCE
dc.subjectHEALTH POLICY
dc.subjectHEALTH SECTOR
dc.subjectHEALTH SYSTEM
dc.subjectHEART DISEASE
dc.subjectHIGH-RISK
dc.subjectHIGH-RISK BEHAVIOR
dc.subjectHIGH-RISK GROUPS
dc.subjectHIV
dc.subjectHIV INFECTED PEOPLE
dc.subjectHIV INFECTIONS
dc.subjectHIV PREVENTION
dc.subjectHIV TESTING
dc.subjectHIV TRANSMISSION
dc.subjectHIV-POSITIVE PEOPLE
dc.subjectHOSPITAL
dc.subjectHOSPITALS
dc.subjectHOUSEHOLD INCOME
dc.subjectHUMAN DEVELOPMENT
dc.subjectHUMAN IMMUNODEFICIENCY VIRUS
dc.subjectILLNESS
dc.subjectIMMUNE SYSTEMS
dc.subjectIMMUNODEFICIENCY
dc.subjectIMPACT ON HEALTH
dc.subjectINSURANCE SCHEMES
dc.subjectINTERVENTION
dc.subjectINTRAVENOUS DRUG USERS
dc.subjectLAB TESTS
dc.subjectLARGE NUMBERS OF PEOPLE
dc.subjectLEGAL STATUS
dc.subjectLONGEVITY
dc.subjectMALARIA
dc.subjectMALE SEX
dc.subjectMEDICAL CARE
dc.subjectMEDICAL SERVICES
dc.subjectMENINGITIS
dc.subjectMODE OF TRANSMISSION
dc.subjectMOTHER
dc.subjectMOTHER-TO-CHILD
dc.subjectNATIONAL AIDS
dc.subjectNATIONAL AIDS PREVENTION
dc.subjectNATIONAL RESOURCES
dc.subjectNEEDLE SHARING
dc.subjectNEW AIDS CASES
dc.subjectNEW CASES
dc.subjectNEW INFECTIONS
dc.subjectNUCLEOSIDE REVERSE
dc.subjectNUMBER OF PEOPLE
dc.subjectNUTRITION
dc.subjectOPPORTUNISTIC ILLNESSES
dc.subjectOPPORTUNISTIC INFECTION
dc.subjectOPPORTUNISTIC INFECTIONS
dc.subjectOUTPATIENT DEPARTMENT
dc.subjectPATIENT
dc.subjectPATIENT CHOICE
dc.subjectPEOPLE LIVING WITH AIDS
dc.subjectPNEUMONIA
dc.subjectPOLICY MAKERS
dc.subjectPREGNANT WOMEN
dc.subjectPREVALENCE
dc.subjectPREVALENCE RATE
dc.subjectPREVALENCE RATES
dc.subjectPREVENTION ACTIVITIES
dc.subjectPREVENTION EFFORTS
dc.subjectPREVENTION OF MOTHER
dc.subjectPREVENTION OF MOTHER-TO-CHILD TRANSMISSION
dc.subjectPROTEASE INHIBITOR
dc.subjectPROTEASE INHIBITORS
dc.subjectPUBLIC HEALTH
dc.subjectPUBLIC HOSPITALS
dc.subjectPUBLIC POLICY
dc.subjectRESISTANT STRAINS
dc.subjectRISK BEHAVIOR
dc.subjectRISK BEHAVIORS
dc.subjectRISK OF TRANSMISSION
dc.subjectRISKY BEHAVIORS
dc.subjectSECOND-LINE REGIMENS
dc.subjectSERVICE DELIVERY
dc.subjectSERVICE PROVIDERS
dc.subjectSEX WITH MEN
dc.subjectSEX WORKERS
dc.subjectSEXUAL CONTACT
dc.subjectSEXUAL RELATIONSHIPS
dc.subjectSEXUALLY TRANSMITTED INFECTIONS
dc.subjectSOCIAL DEVELOPMENT
dc.subjectSOCIAL SECURITY
dc.subjectSPILLOVER
dc.subjectT-CELL
dc.subjectTHERAPY
dc.subjectTRANSMISSION
dc.subjectTRIPLE-DRUG COMBINATION
dc.subjectTUBERCULOSIS
dc.subjectUNAIDS
dc.subjectVIRAL LOADS
dc.subjectVOLUNTARY COUNSELING
dc.subjectWORLD HEALTH ORGANIZATION
dc.subjectYOUTH
dc.titleThe Economics of Effective AIDS Treatment : Evaluating Policy Options for Thailanden
dspace.entity.typePublication
okr.date.disclosure2006-10-02
okr.doctypePublications & Research::Publication
okr.doctypePublications & Research::Publication
okr.docurlhttp://documents.worldbank.org/curated/en/2006/01/7082805/economics-effective-aids-treatment-evaluating-policy-options-thailand
okr.globalpracticeHealth, Nutrition, and Population
okr.guid158831468118458875
okr.guid744851468132274418
okr.identifier.doi10.1596/978-0-8213-6755-1
okr.identifier.externaldocumentum000310607_20060926124315
okr.identifier.internaldocumentum7082805
okr.identifier.report37449
okr.language.supporteden
okr.pdfurlhttp://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2006/09/26/000310607_20060926124315/Rendered/PDF/374490TH0Economics0aids01PUBLIC1.pdfen
okr.peerreviewAcademic Peer Review
okr.region.administrativeEast Asia and Pacific
okr.region.countryThailand
okr.region.geographicalAsia
okr.region.geographicalSoutheast Asia
okr.topicHealth, Nutrition and Population::HIV AIDS
okr.topicHealth Monitoring and Evaluation
okr.topicHealth, Nutrition and Population::Adolescent Health
okr.topicHealth, Nutrition and Population::Population Policies
okr.topicDisease Control and Prevention
okr.topicHealth, Nutrition and Population
okr.unitGlobal HIV/AIDS Program (HDNGA)
okr.volume1 of 1
relation.isAuthorOfPublication8de50a92-441d-5d2d-8305-8ee708b0f79d
relation.isAuthorOfPublication.latestForDiscovery8de50a92-441d-5d2d-8305-8ee708b0f79d
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
374490TH0Economics0aids01PUBLIC1.pdf
Size:
6.2 MB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
374490TH0Economics0aids01PUBLIC1.txt
Size:
635.13 KB
Format:
Plain Text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Health, Nutrition and Population